This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Drug-induced hyponatraemia

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Drug-induced hyponatraemia occurs in approximately 5% of outpatients and 15% of inpatients (1)

  • in an Australian study the commonest drugs causing hyponatraemia were:
    • indapamide
    • sertraline
    • amiloride/hydrochlorothiazide
    • carbamazepine
    • furosemide
    • fluoxetine

  • most patients with hyponatraemia are diagnosed incidentally on routine blood tests

Example causes of drug induced hyponatraemia:

Diuretics

  • thiazide diuretics
    • indapamide
    • chlorothiazide
  • combination diuretics
    • amiloride/hydrochlorothiazide
  • loop diuretics
    • furosemide

Anticonvulsants

  • carbamazepine

ACE inhibitor

  • enalapril
  • ramipril

COX2 inhibitor

  • celecoxib

Hypnotics

  • temazepam

Sulphonylureas

  • gliclazide
  • glimepiride
  • glibenclamide
  • glipizide

Proton pump inhibitor

  • omeprazole
  • pantoprazole

Hormonal analogue

  • desmopressin
  • oxytocin

Antidepressants

  • SSRIs
    • sertraline
    • fluoxetine
    • citalopram
    • paroxetine
    • venlafaxine
  • MAOI
    • moclobemide

Recreational drugs

  • ecstasy

 

Reference:

  • Fourlanos S, Greenberg . Managing drug-induced hyponatraemia in adults.Aust Prescr: 2003;26:114-7.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.